Literature DB >> 16155135

Short-term outcome of intracranial aneurysms treated with polyglycolic acid/lactide copolymer-coated coils compared to historical controls treated with bare platinum coils: a single-center experience.

Hyun-Seung Kang1, Moon Hee Han, Bae Ju Kwon, O-Ki Kwon, Sung Hyun Kim, Seung Hong Choi, Kee-Hyun Chang.   

Abstract

BACKGROUND AND
PURPOSE: Aneurysm recanalization is an innate problem in endovascular treatment of aneurysms with coils. A coated coil system, covered with a bioabsorbable polymeric material (polyglycolic acid/lactide copolymer, PGLA), was developed to accelerate intra-aneurysmal clot organization and fibrosis. The purpose of this study was to evaluate the efficacy and safety of the PGLA-coated coils in patients with intracranial aneurysms and to compare the outcome with that of bare platinum coils. PATIENTS AND TECHNIQUES: Fifty-one patients harboring 56 intracranial aneurysms underwent endovascular embolization with the PGLA-coated coils. In the control group were 78 consecutive patients, harboring 87 aneurysms, who underwent coil embolization with bare platinum coils. The authors compared coil volume, packing attenuation, degree of occlusion of aneurysms, procedure-related complications, and follow-up results between the 2 groups.
RESULTS: The PGLA-coil group showed comparable data regarding rate of total or near-total occlusion of the aneurysm, incidence procedure-related thromboembolism, and management outcome. Mean coil volume deployed and packing attenuation of the PGLA-coil group were significantly higher than those of the bare-coil group (P = .0026 and P < .0001, respectively). Radiologic follow-up evaluation revealed recanalization in 14 of 39 aneurysms (major recanalization in 5 [13%] and minor recanalization in 9 [23%]) among the PGLA-coil group and in 29 of 64 aneurysms (major recanalization in 9 [14%] and minor recanalization in 20 [31%]) among the bare-coil group.
CONCLUSION: In this study, the incidence of recanalization was not different in aneurysms treated with PGLA-coated coils compared with historical controls treated with bare platinum coils.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16155135      PMCID: PMC8148862     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  20 in total

Review 1.  Topic review: surface modifications enhancing biological activity of guglielmi detachable coils in treating intracranial aneurysms.

Authors:  J M Abrahams; S L Diamond; R W Hurst; E L Zager; M S Grady
Journal:  Surg Neurol       Date:  2000-07

2.  Guglielmi detachable coil embolization of acute intracranial aneurysm: perioperative anatomical and clinical outcome in 403 patients.

Authors:  F Viñuela; G Duckwiler; M Mawad
Journal:  J Neurosurg       Date:  1997-03       Impact factor: 5.115

3.  Intracranial Aneurysm Embolization Using Interlocking Detachable Coils. Correlation between Volume Embolization Rate and Coil Compaction.

Authors:  K Satoh; S Matsubara; H Hondoh; S Nagahiro
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

4.  Bioabsorbable polymeric material coils for embolization of intracranial aneurysms: a preliminary experimental study.

Authors:  Y Murayama; F Viñuela; S Tateshima; J K Song; N R Gonzalez; M P Wallace
Journal:  J Neurosurg       Date:  2001-03       Impact factor: 5.115

5.  Evaluation of the stability of aneurysms after embolization using detachable coils: correlation between stability of aneurysms and embolized volume of aneurysms.

Authors:  Shinichi Tamatani; Yasushi Ito; Hiroshi Abe; Tetsuo Koike; Shigekazu Takeuchi; Ryuichi Tanaka
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

6.  Cellular responses of bioabsorbable polymeric material and Guglielmi detachable coil in experimental aneurysms.

Authors:  Yuichi Murayama; Fernando Viñuela; Satoshi Tateshima; Nestor R Gonzalez; Joon K Song; Haleh Mahdavieh; Luisa Iruela-Arispe
Journal:  Stroke       Date:  2002-04       Impact factor: 7.914

7.  Significance of volume embolization ratio as a predictor of recanalization on endovascular treatment of cerebral aneurysms with guglielmi detachable coils.

Authors:  N Uchiyama; S Kida; M Nomura; M Hasegawa; T Yamashima; J Yamashita; O Matsui
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

8.  Matrix and bioabsorbable polymeric coils accelerate healing of intracranial aneurysms: long-term experimental study.

Authors:  Yuichi Murayama; Satoshi Tateshima; Nestor R Gonzalez; Fernando Vinuela
Journal:  Stroke       Date:  2003-07-17       Impact factor: 7.914

9.  Long-term angiographic recurrences after selective endovascular treatment of aneurysms with detachable coils.

Authors:  Jean Raymond; François Guilbert; Alain Weill; Stavros A Georganos; Louis Juravsky; Anick Lambert; Julie Lamoureux; Miguel Chagnon; Daniel Roy
Journal:  Stroke       Date:  2003-05-29       Impact factor: 7.914

10.  Guglielmi detachable coil embolization of cerebral aneurysms: 11 years' experience.

Authors:  Yuichi Murayama; Yih Lin Nien; Gary Duckwiler; Y Pierre Gobin; Reza Jahan; John Frazee; Neil Martin; Fernando Viñuela
Journal:  J Neurosurg       Date:  2003-05       Impact factor: 5.115

View more
  23 in total

1.  Endovascular treatment of intracranial aneurysms with matrix coils: immediate posttreatment results, clinical outcome and follow-up.

Authors:  T Jonas Kimchi; R A Willinsky; J Spears; S K Lee; K ter Brugge
Journal:  Neuroradiology       Date:  2007-01-03       Impact factor: 2.804

Review 2.  Materials and techniques for coiling of cerebral aneurysms: how much scientific evidence do we have?

Authors:  W Kurre; J Berkefeld
Journal:  Neuroradiology       Date:  2008-09-19       Impact factor: 2.804

3.  Microguidewire protection of wide-necked aneurysms incorporating orifices of tortuous acute-angled vessels: a novel approach.

Authors:  Young Dae Cho; Hyun-Seung Kang; Jeong Eun Kim; Jun Hyong Ahn; Seung Chai Jung; Chang Hun Kim; Moon Hee Han
Journal:  Neuroradiology       Date:  2014-04-23       Impact factor: 2.804

4.  Modified coil protection for proper coil frame configuration in wide-necked aneurysms.

Authors:  Young Dae Cho; Jong Kook Rhim; Jeong Jin Park; Jin Pyeong Jeon; Hyun-Seung Kang; Jeong Eun Kim; Won-Sang Cho; Moon Hee Han
Journal:  Neuroradiology       Date:  2015-03-28       Impact factor: 2.804

5.  Matrix² coils in embolization of intracranial aneurysms: 1-year outcome and comparison with bare platinum coil group in a single institution.

Authors:  S W Youn; S-H Cha; H-S Kang; Y D Cho; M H Han
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-15       Impact factor: 3.825

6.  Embolization of intracranial aneurysms with HydroSoft coils: results of the Korean multicenter study.

Authors:  J H Park; H-S Kang; M H Han; P Jeon; D-S Yoo; T H Lee
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-15       Impact factor: 3.825

7.  Coil embolization in precommunicating (A1) segment aneurysms of anterior cerebral artery.

Authors:  Young Dae Cho; Jun Hyong Ahn; Seung Chai Jung; Chang Hun Kim; Hyun-Seung Kang; Jeong Eun Kim; Young Je Son; Moon Hee Han
Journal:  Neuroradiology       Date:  2014-01-26       Impact factor: 2.804

8.  Endovascular treatment of intracranial aneurysms with matrix detachable coils: midterm anatomic follow-up from a prospective multicenter registry.

Authors:  L Pierot; X Leclerc; A Bonafé; S Bracard
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-05       Impact factor: 3.825

9.  MR angiographic evaluation is limited in intracranial aneurysms embolized with Nexus coils.

Authors:  Hyun-Seung Kang; Won-Jin Moon; Hong Gee Roh; Moon Hee Han; Woo Jin Choe; Joon Cho; Chang-Taek Moon; Young Cho Koh
Journal:  Neuroradiology       Date:  2007-10-25       Impact factor: 2.804

10.  Single-institution experience with matrix coils in the treatment of intracranial aneurysms: comparison with same-center outcomes with the use of platinum coils.

Authors:  D J Rivet; C J Moran; A Mazumdar; T K Pilgram; C P Derdeyn; D T Cross
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-20       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.